Cera Sanitaryware Limited has informed the Exchange about Transcript
CERA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cera Sanitaryware reported Q4 FY25 revenue of Rs. 578 crore, up 5.7% year-on-year, with profit after tax rising 14.1% to Rs. 86 crore. EBITDA margin (excluding other income) improved 150 basis points to 18.3%, driven by 0.5% savings on publicity spend, 0.9% from cost efficiencies, and 0.1% gross margin gains. The B2B/project business grew to 40% of revenue (up from 35% a year ago), with strong pre-order momentum from real estate, while retail demand remained subdued for six consecutive quarters. Faucetware grew 9.6% but Sanitaryware declined 1.6%; management reiterated the Rs. 2,900 crore FY27 revenue aspiration, contingent on a retail recovery. The company holds Rs. 719 crore in cash, plans Rs. 24 crore CAPEX in FY26, and has kept the Sanitaryware capacity expansion on hold while ramping up 40-45 new Senator premium stores.
Steady Q4 with margin expansion, strong cash position (Rs. 719 crore), and rising B2B share are positives, but prolonged retail softness and deferred capacity expansion signal near-term caution. The FY27 revenue target of Rs. 2,900 crore remains aspirational and dependent on a retail recovery that has not yet shown up in the data.